Ann Mander

1.5k total citations
24 papers, 966 citations indexed

About

Ann Mander is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ann Mander has authored 24 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ann Mander's work include Immunotherapy and Immune Responses (6 papers), Neonatal Respiratory Health Research (3 papers) and vaccines and immunoinformatics approaches (3 papers). Ann Mander is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Neonatal Respiratory Health Research (3 papers) and vaccines and immunoinformatics approaches (3 papers). Ann Mander collaborates with scholars based in United Kingdom, United States and Germany. Ann Mander's co-authors include Christian H. Ottensmeier, John O. Warner, Anthony D. Postle, Conrad P. Hodgkinson, Graham J. Sale, Jiu‐Yao Wang, Maria Moustaki, Sarah Wright, Kenneth B. M. Reid and Freda K. Stevenson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Biochemical Journal.

In The Last Decade

Ann Mander

22 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Mander United Kingdom 15 383 320 246 230 103 24 966
J Fujimoto Japan 16 253 0.7× 282 0.9× 98 0.4× 152 0.7× 105 1.0× 30 897
S. Kishimoto Japan 19 575 1.5× 349 1.1× 101 0.4× 170 0.7× 236 2.3× 61 1.5k
Hongxiu Ji United States 17 411 1.1× 440 1.4× 140 0.6× 267 1.2× 302 2.9× 42 1.4k
Timothy C. Rodell United States 17 329 0.9× 328 1.0× 126 0.5× 202 0.9× 356 3.5× 36 1.2k
John O. Phillips United States 15 283 0.7× 384 1.2× 100 0.4× 350 1.5× 177 1.7× 26 1.3k
Kenneth Verstraete Belgium 15 353 0.9× 313 1.0× 97 0.4× 121 0.5× 51 0.5× 27 1.0k
H. Gallati Switzerland 13 601 1.6× 216 0.7× 68 0.3× 143 0.6× 175 1.7× 35 1.1k
G Damiani Italy 21 416 1.1× 343 1.1× 86 0.3× 70 0.3× 131 1.3× 52 1.1k
Tetsuo Mori Japan 20 657 1.7× 239 0.7× 68 0.3× 117 0.5× 124 1.2× 41 1.3k
Yunwei Lou China 16 442 1.2× 612 1.9× 151 0.6× 174 0.8× 141 1.4× 34 1.2k

Countries citing papers authored by Ann Mander

Since Specialization
Citations

This map shows the geographic impact of Ann Mander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Mander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Mander more than expected).

Fields of papers citing papers by Ann Mander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Mander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Mander. The network helps show where Ann Mander may publish in the future.

Co-authorship network of co-authors of Ann Mander

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Mander. A scholar is included among the top collaborators of Ann Mander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Mander. Ann Mander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCann, Katy J., Lindsey Chudley, Ann Mander, et al.. (2015). Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study. Cancer Immunology Immunotherapy. 64(8). 1021–1032. 25 indexed citations
2.
Chudley, Lindsey, Katy J. McCann, Ann Mander, et al.. (2012). DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time. Cancer Immunology Immunotherapy. 61(11). 2161–2170. 77 indexed citations
3.
Stevenson, Freda K., Ann Mander, Lindsey Chudley, & Christian H. Ottensmeier. (2011). DNA fusion vaccines enter the clinic. Cancer Immunology Immunotherapy. 60(8). 1147–1151. 16 indexed citations
4.
Mander, Ann, Cécile Gouttefangeas, Christian H. Ottensmeier, et al.. (2010). Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program. Cancer Immunology Immunotherapy. 59(4). 619–627. 15 indexed citations
5.
Moodie, Zoe, Leah Price, Cécile Gouttefangeas, et al.. (2010). Response definition criteria for ELISPOT assays revisited. Cancer Immunology Immunotherapy. 59(10). 1489–1501. 149 indexed citations
6.
Ottensmeier, Christian H., Ann Mander, Katy J. McCann, et al.. (2010). Clinical and immunological responses to a DNA fusion vaccine in patients with carcinoembryonic antigen-expressing tumors: A Cancer Research UK phase I/II study.. Journal of Clinical Oncology. 28(15_suppl). 2579–2579. 1 indexed citations
7.
Mander, Ann, Katy J. McCann, David P. Dearnaley, et al.. (2009). DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer. Human Gene Therapy. 20(11). 1269–1278. 128 indexed citations
8.
9.
Mander, Ann, Conrad P. Hodgkinson, & Graham J. Sale. (2005). Knock‐down of LAR protein tyrosine phosphatase induces insulin resistance. FEBS Letters. 579(14). 3024–3028. 19 indexed citations
10.
Hodgkinson, Conrad P., Ann Mander, & Graham J. Sale. (2005). Protein kinase-ζ interacts with munc18c: role in GLUT4 trafficking. Diabetologia. 48(8). 1627–1636. 30 indexed citations
11.
Mander, Ann, Simon C Langton Hewer, Wolfgang Bernhard, John O. Warner, & Anthony D. Postle. (2002). Altered Phospholipid Composition and Aggregate Structure of Lung Surfactant Is Associated with Impaired Lung Function in Young Children with Respiratory Infections. American Journal of Respiratory Cell and Molecular Biology. 27(6). 714–721. 54 indexed citations
12.
Postle, Anthony D., Ann Mander, Kenneth B. M. Reid, et al.. (1999). Deficient Hydrophilic Lung Surfactant Proteins A and D with Normal Surfactant Phospholipid Molecular Species in Cystic Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 20(1). 90–98. 189 indexed citations
13.
Burdge, Graham C., Ann Mander, & Anthony D. Postle. (1996). Hepatic and plasma phospholipid molecular species compositions in the pregnant guinea pig: Effect of chronic ethanol consumption. The Journal of Nutritional Biochemistry. 7(8). 425–430. 1 indexed citations
14.
Murphy, Denis J., et al.. (1991). Metallothionein levels in ovarian tumours before and after chemotherapy. British Journal of Cancer. 63(5). 711–714. 35 indexed citations
15.
Barnett, A H, et al.. (1980). Management of premature labour in diabetic pregnancy. Diabetologia. 18(5). 365–368. 8 indexed citations
16.
Mander, Ann. (1978). Functions and priorities of the BMA. BMJ. 1(6119). 1057.2–1057.
17.
Bolton, P.M., C. Teasdale, Ann Mander, et al.. (1976). Immune competence in breast cancer ? Relationship of pretreatment immunologic tests to diagnosis and tumor stage. Cancer Immunology Immunotherapy. 1(4). 22 indexed citations
18.
Bolton, P.M., et al.. (1975). Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers.. BMJ. 3(5974). 18–20. 48 indexed citations
19.
Mander, Ann, P.M. Bolton, R. H. Whitehead, Robert G. Newcombe, & L E Hughes. (1975). Proceedings: Immune competence in colon cancer: relationship of pretreatment tests to diagnosis and tumour stage. British Journal of Cancer. 32(2). 243–243.
20.
Serrou, B, J.B. Dubois, M Robinet-Lévy, et al.. (1975). IgE SERUM-LEVELS IN CANCER PATIENTS. The Lancet. 305(7903). 396–397. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Fujimoto Breakdown of academic impact, for papers by S. Kishimoto Breakdown of academic impact, for papers by Hongxiu Ji Breakdown of academic impact, for papers by Timothy C. Rodell Breakdown of academic impact, for papers by John O. Phillips Breakdown of academic impact, for papers by Kenneth Verstraete Breakdown of academic impact, for papers by H. Gallati Breakdown of academic impact, for papers by G Damiani Breakdown of academic impact, for papers by Tetsuo Mori Breakdown of academic impact, for papers by Yunwei Lou
Rankless by CCL
2026